Contraceptives Drugs and Devices Market Report – Research, Industry Analysis Reports and Market Demands

Global Contraceptives Drugs and Devices Market Insights, Forecast to 2025

Request for Sample of this report

Buy now

Table of Content

1 Study Coverage

1.1 Contraceptives Drugs and Devices Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
- 1.4.1 Global Contraceptives Drugs and Devices Market Size Growth Rate by Product
- 1.4.2 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
- 1.4.3 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
1.5 Market by End User
- 1.5.1 Global Contraceptives Drugs and Devices Market Size Growth Rate by End User
- 1.5.2 Female
- 1.5.3 Male
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Contraceptives Drugs and Devices Market Size
- 2.1.1 Global Contraceptives Drugs and Devices Revenue 2014-2025
- 2.1.2 Global Contraceptives Drugs and Devices Sales 2014-2025
2.2 Contraceptives Drugs and Devices Growth Rate by Regions
- 2.2.1 Global Contraceptives Drugs and Devices Sales by Regions
- 2.2.2 Global Contraceptives Drugs and Devices Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Contraceptives Drugs and Devices Sales by Manufacturers
- 3.1.1 Contraceptives Drugs and Devices Sales by Manufacturers
- 3.1.2 Contraceptives Drugs and Devices Sales Market Share by Manufacturers
- 3.1.3 Global Contraceptives Drugs and Devices Market Concentration Ratio (CR5 and HHI)
3.2 Contraceptives Drugs and Devices Revenue by Manufacturers
- 3.2.1 Contraceptives Drugs and Devices Revenue by Manufacturers (2014-2019)
- 3.2.2 Contraceptives Drugs and Devices Revenue Share by Manufacturers (2014-2019)
3.3 Contraceptives Drugs and Devices Price by Manufacturers
3.4 Contraceptives Drugs and Devices Manufacturing Base Distribution, Product Types
- 3.4.1 Contraceptives Drugs and Devices Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Contraceptives Drugs and Devices Product Type
- 3.4.3 Date of International Manufacturers Enter into Contraceptives Drugs and Devices Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Contraceptives Drugs and Devices Sales by Product
4.2 Global Contraceptives Drugs and Devices Revenue by Product
4.3 Contraceptives Drugs and Devices Price by Product

5 Breakdown Data by End User

5.1 Overview
5.2 Global Contraceptives Drugs and Devices Breakdown Data by End User

6 North America

6.1 North America Contraceptives Drugs and Devices by Countries
- 6.1.1 North America Contraceptives Drugs and Devices Sales by Countries
- 6.1.2 North America Contraceptives Drugs and Devices Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
6.2 North America Contraceptives Drugs and Devices by Product
6.3 North America Contraceptives Drugs and Devices by End User

7 Europe

7.1 Europe Contraceptives Drugs and Devices by Countries
- 7.1.1 Europe Contraceptives Drugs and Devices Sales by Countries
- 7.1.2 Europe Contraceptives Drugs and Devices Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
7.2 Europe Contraceptives Drugs and Devices by Product
7.3 Europe Contraceptives Drugs and Devices by End User

8 Asia Pacific

8.1 Asia Pacific Contraceptives Drugs and Devices by Countries
- 8.1.1 Asia Pacific Contraceptives Drugs and Devices Sales by Countries
- 8.1.2 Asia Pacific Contraceptives Drugs and Devices Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
8.2 Asia Pacific Contraceptives Drugs and Devices by Product
8.3 Asia Pacific Contraceptives Drugs and Devices by End User

9 Central & South America

9.1 Central & South America Contraceptives Drugs and Devices by Countries
- 9.1.1 Central & South America Contraceptives Drugs and Devices Sales by Countries
- 9.1.2 Central & South America Contraceptives Drugs and Devices Revenue by Countries
- 9.1.3 Brazil
9.2 Central & South America Contraceptives Drugs and Devices by Product
9.3 Central & South America Contraceptives Drugs and Devices by End User

10 Middle East and Africa

10.1 Middle East and Africa Contraceptives Drugs and Devices by Countries
- 10.1.1 Middle East and Africa Contraceptives Drugs and Devices Sales by Countries
- 10.1.2 Middle East and Africa Contraceptives Drugs and Devices Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
10.2 Middle East and Africa Contraceptives Drugs and Devices by Product
10.3 Middle East and Africa Contraceptives Drugs and Devices by End User

11 Company Profiles

12 Future Forecast

12.1 Contraceptives Drugs and Devices Market Forecast by Regions
- 12.1.1 Global Contraceptives Drugs and Devices Sales Forecast by Regions 2019-2025
- 12.1.2 Global Contraceptives Drugs and Devices Revenue Forecast by Regions 2019-2025
12.2 Contraceptives Drugs and Devices Market Forecast by Product
- 12.2.1 Global Contraceptives Drugs and Devices Sales Forecast by Product 2019-2025
- 12.2.2 Global Contraceptives Drugs and Devices Revenue Forecast by Product 2019-2025
12.3 Contraceptives Drugs and Devices Market Forecast by End User
12.4 North America Contraceptives Drugs and Devices Forecast
12.5 Europe Contraceptives Drugs and Devices Forecast
12.6 Asia Pacific Contraceptives Drugs and Devices Forecast
12.7 Central & South America Contraceptives Drugs and Devices Forecast
12.8 Middle East and Africa Contraceptives Drugs and Devices Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis
14.2 Contraceptives Drugs and Devices Customers
14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
16.2 Author Details

Description

Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects.
The global Contraceptives Drugs and Devices market is valued at 19000 million US$ in 2018 and will reach 34600 million US$ by the end of 2025, growing at a CAGR of 7.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Contraceptives Drugs and Devices market based on company, product type, end user and key regions.

This report studies the global market size of Contraceptives Drugs and Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Contraceptives Drugs and Devices in these regions.
This research report categorizes the global Contraceptives Drugs and Devices market by top players/brands, region, type and end user. This report also studies the global Contraceptives Drugs and Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Teva Pharmaceutical Industries Ltd
Church & Dwight Co. Inc
Reckitt Benckiser Plc
Pfizer, Inc
Bayer AG
Mayer Laboratories, Inc
The Female Health Company
Cooper Surgical, Inc
Allergan plc
Cipla Limited
Merck & Co. Inc

Market size by Product
Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Market size by End User
Female
Male

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Contraceptives Drugs and Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Contraceptives Drugs and Devices market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Contraceptives Drugs and Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Contraceptives Drugs and Devices submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Contraceptives Drugs and Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Contraceptives Drugs and Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.